In This Section

Program

Please note that this meeting will take place as an in-person event in Gyeongju, Korea and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

[R] – Remote Presentation

Thursday, November 12

Friday, November 14

Thursday, November 12

Educational Session 1: AI-Driven Clinical Transformation in Oncology 

  • Beyond the microscope; AI-powered advances in precision oncology
    Sangjeong Ahn, Korea University College of Medicine, Korea
  • Imaging AI in breast cancer: Clinical impact beyond detection
    Eun Kyung Park, Seoul National University College of Medicine, Korea
  • Reading the hidden code of cancer in routine pathology with AI: from tissue patterns to personalized cancer care
    Kun-Hsing Yu, Harvard Medical School, Boston, Massachusetts, USA

Break

9:50-10:05 a.m.

Opening Remarks

10:05-10:15 a.m.

  • Hoon Hur, Ajou University School of Medicine, Korea
  • Keith T. Flaherty, Harvard Medical School, Boston, Massachusetts, USA

Plenary Session 1: Liquid Biopsy for precision oncology

  • MUTE-Seq: CRISPR-driven innovation for unmet needs in liquid biopsy
    Junseok Hur, Korea University College of Medicine, Korea
  • Maximillian Diehn, Stanford University, Stanford, California, USA
  • Extracellular vesicles as predictive biomarkers for ICI therapy: From nanoscale engineering to clinical applications
    Jiyoon Bu, Inha University School of Biosystems Convergence, Korea
  • Raghu Kalluri, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA    

Luncheon Symposia

12:05- 12:45 p.m.

Poster Session A / Break

12:34-1:15 p.m.

Keynote Lecture

1:15-1:55 p.m.

  • Introduction of Keynote Lecturer
    Keith T. Flaherty, Mass. General Hospital, Boston, Massachusetts, USA                     
  • Keynote Lecture
    Alexander K. Shalek, MIT, Cambridge, Massachusetts ,USA

Plenary Session 2: Emerging Modalities in Surface Targeting: ADCs and Beyond 

2:05-3:45 p.m.

  • Development of NK cell-drug conjugates via membrane-immobilized anticancer therapeutics
    Kyobum Kim, Dongguk University College of Engineering, Korea
  • Irene M. Ghobrial, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
  • Protein nanoparticle platforms for targeting surface molecules in cancer
    Sebyung Kang, UNIST, Korea
  • Alana Welm, Huntsman Cancer Institute, Salt Lake City, Utah, USA

Break

3:45-4 p.m.

Plenary Session 3: Microbiome and Cancer Therapy

4-5:40 p.m.

  • Microbial metabolites control progression of cervical cancer
    Youngtae Jeong (DGIST, Korea)
  • The tumor microbiome and its effects on the response to immunotherapy
    Ravid Straussman, Weizmann Institute of Science, Rehovat, Israel
  • Microbiome-based markers to improve the efficacy of cancer therapy
    In Suk Lee, Yonsei University, Korea
  • Arielle Elkrief, University of Montreal/CHUM, Montreal, Quebec, Canada

FAculty Dinner

6:30 p.m.

Friday, November 13

Educational Session 2: Applied Chemistry Advances and Next-Generation Drug Discovery 

8:30- 9:50 a.m.

  • CREB:CBP Interaction for treatment of acute myeloid leukemia
    Kathleen Sakamoto, Stanford University, Stanford, California, USA
  • DNA-encoded chemical libraries for drug discovery
    Hyun-Suk Lim, POSTECH, Korea
  • New therapeutic opportunities in ferroptosis and metabolism biology
    Brent R. Stockwell, Columbia University, New York, NY, USA

Break

9:50-10:10 a.m.

Plenary Session 4: Advances in precision medicine in hematological malignancies

10:10-11:50 a.m.

  • Incomplete intestinal metaplasia as a precursor to gastric cancer: Integrated spatial, single-cell and epigenetic insights
    Bogun Jang, Jeju National University College of Medicine, Korea
  • Patrick Tan, Duke-NUS, Singapore
  • Molecular phenotype related to ICI response in GC
    Jeeyun Lee, Sungkyunkwan University School of Medicine, Korea
  • Expanding and Understanding the Target Universe in Gastric Cancer
    Samuel J. Klempner, Massachusetts General Hospital, Boston, Massachusetts, USA

Waun Ki Hong Memorial Lecture 

12- 12:40 p.m.

  • Introduction of Waun Ki Hong Memorial Lecturer
    Hoon Hur, Ajou University School of Medicine, Korea  
  • Rethinking tumor-infiltrating T cells to improve cancer immunotherapy
    Eui-Cheol Shin, KAIST, Korea                    

Luncheon Symposia

12:50-1:30

Poster Session B / Break

1:30- 2 p.m.

Posters will be on display from 08:30 5:30 with official viewing session from 1:10-1:40

Plenary Session 5: Spatial Omics and Tumor Evolution

2-3:40 p.m.

  • Peter Van Loo, UT MD Anderson Cancer Center, Houston, TX, USA
  • Lineage tracing cancer evolution
    Trevor Graham, The Institute of Cancer Research, London, UK
  • Beyond the tumor mass: Tracing brain tumor origins in histologically normal tissues
    Seok-Gu Kang, Yonsei University College of Medicine, Korea
  • Tumor evolutionary change of breast cancer
    Yeon Hee Park, Sungkyunkwan University School of Medicine, Korea

Break

3:40-4 p.m.

Plenary Session 6: Precision Immunotherapy: Identifying and Targeting Immune-Evasive Tumors

4-5:40 p.m.

  • Metabolic impact on tumor resistance to immunotherapy
    Weiping Zou, University of Michigan, Ann Arbor, Michigan, USA
  • Microfabricated platforms for cancer immunotherapy
    Jun-Sang Doh, Seoul National University College of Engineering, Korea
  • Learning from human tumors: PDOTS as a platform for discovery and prioritization of novel cancer immunotherapy targets
    Russel W. Jenkins, Medical University of South Carolina, Charleston, SC, USA
  • Response prediction to immune-checkpoint inhibitor in hepatobiliary cancer
    Hong Jae Chon, CHA University School of Medicine, Korea

Awards and Closing Ceremony

5:40 p.m.